开云app官网登录入口网页版-官方正版

#奥马珠单抗#

5篇内容 | 2417人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1241546, encodeId=b18712415467f, content=<a href='/topic/show?id=fe154458548' target=_blank style='color:#2F92EE;'>#奥马珠单抗#</a>治疗慢性<a href='/topic/show?id=1adb8e27181' target=_blank style='color:#2F92EE;'>#荨麻疹#</a>, objectTitle=抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识, objectType=guider, longId=17087, objectId=a17b01c002a448b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=a17b01c002a448b1, replyNumber=0, likeNumber=92, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a17b01c002a448b1, moduleTitle=抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识, moduleType=guider, hrefUrl=//www.sandwebs.com/guideline/show_article.do?id=a17b01c002a448b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241547, encodeId=84f8124154eec, content=<a href='/topic/show?id=fe154458548' target=_blank style='color:#2F92EE;'>#奥马珠单抗#</a>, objectTitle=奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代, objectType=article, longId=267099, objectId=00db26e09956, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220414/1649929108411_92910.png, objectUrl=/article/show_article.do?id=00db26e09956, replyNumber=0, likeNumber=104, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00db26e09956, moduleTitle=奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=00db26e09956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241548, encodeId=4c5f12415485a, content=<a href='/topic/show?id=fe154458548' target=_blank style='color:#2F92EE;'>#奥马珠单抗#</a><a href='/topic/show?id=df1269423df' target=_blank style='color:#2F92EE;'>#生物类似物#</a>这么快就有了, objectTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), objectType=article, longId=295364, objectId=dce229536434, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202229/1644390214676_5444305.png, objectUrl=/article/show_article.do?id=dce229536434, replyNumber=0, likeNumber=89, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce229536434, moduleTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=dce229536434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=977301, encodeId=86cb9e73011a, content=<a href='/topic/show?id=fe154458548' target=_blank style='color:#2F92EE;'>#奥马珠单抗#</a>治疗<a href='/topic/show?id=12bd103450fa' target=_blank style='color:#2F92EE;'>#鼻息肉#</a>?息肉是因为炎症或过敏引起的？？, objectTitle=J Allergy Clin Immunol：奥马珠单抗治疗鼻息肉病的疗效和安全性：2项随机3期试验, objectType=article, longId=213346, objectId=ada3213346da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/098.jpg, objectUrl=/article/show_article.do?id=ada3213346da, replyNumber=0, likeNumber=121, createdTime=2021-06-27, rootId=0, userName=小小医者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ada3213346da, moduleTitle=J Allergy Clin Immunol：奥马珠单抗治疗鼻息肉病的疗效和安全性：2项随机3期试验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ada3213346da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=884329, encodeId=ccad8843293e, content=<a href='/topic/show?id=fe154458548' target=_blank style='color:#2F92EE;'>#奥马珠单抗#</a>Omalizumab确实是好东西，对<a href='/topic/show?id=c0ae9405422' target=_blank style='color:#2F92EE;'>#过敏性鼻炎#</a>和<a href='/topic/show?id=052d399242a' target=_blank style='color:#2F92EE;'>#哮喘#</a>都有很好的预防和治疗作用，就是太贵了些, objectTitle=Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？, objectType=article, longId=200537, objectId=472f20053e7b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599742572921_1935437.jpg, objectUrl=/article/show_article.do?id=472f20053e7b, replyNumber=0, likeNumber=236, createdTime=2020-09-10, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472f20053e7b, moduleTitle=Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=472f20053e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

奥马珠单抗

2020-05-29

循证小兵 (审核中...)

前往app查看评论内容

#奥马珠单抗#治疗慢性#荨麻疹#

抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#奥马珠单抗#

奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#奥马珠单抗##生物类似物#这么快就有了

Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23)

2022-08-28

小小医者 (审核中...)

前往app查看评论内容

#奥马珠单抗#治疗#鼻息肉#?息肉是因为炎症或过敏引起的？？

J Allergy Clin Immunol：奥马珠单抗治疗鼻息肉病的疗效和安全性：2项随机3期试验

2021-06-27

lovetcm (审核中...)

前往app查看评论内容

#奥马珠单抗#Omalizumab确实是好东西，对#过敏性鼻炎#和#哮喘#都有很好的预防和治疗作用，就是太贵了些

Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？

2020-09-10

科室
- - 订阅+
  - 更多科室
工具
服务